Cargando…

UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates

The continuing emergence of SARS-CoV-2 variants calls for regular assessment to identify differences in viral replication, shedding and associated disease. In this study, we compared African green monkeys infected intranasally with either the UK B.1.1.7 (Alpha) variant or its contemporary D614G prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenke, Kyle, Feldmann, Friederike, Okumura, Atsushi, Hansen, Frederick, Tang-Huau, Tsing-Lee, Meade-White, Kimberly, Kaza, Benjamin, Callison, Julie, Lewis, Matthew C., Smith, Brian J., Hanley, Patrick W., Lovaglio, Jamie, Jarvis, Michael A., Shaia, Carl, Feldmann, Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Emerging and Re-Emerging Coronaviruses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635622/ https://www.ncbi.nlm.nih.gov/pubmed/34724885 http://dx.doi.org/10.1080/22221751.2021.1997074

Ejemplares similares

UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, K., et al.
Publicado: (2021)

Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates
por: Bhatia, Bharti, et al.
Publicado: (2023)

Development of a nonhuman primate model for mammalian bornavirus infection
por: Schlottau, Kore, et al.
Publicado: (2022)

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
por: Hu, Yanping, et al.
Publicado: (2023)

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
por: Faraone, Julia N., et al.
Publicado: (2023)

SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response
por: Mileto, D., et al.
Publicado: (2021)

Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status
por: Boschi, Celine, et al.
Publicado: (2021)

A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality
por: Camelo, Serge, et al.
Publicado: (2021)

Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination
por: Iketani, Sho, et al.
Publicado: (2021)

Susceptibility of livestock to SARS-CoV-2 infection
por: Bosco-Lauth, Angela M., et al.
Publicado: (2021)

Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination
por: Suryawanshi, Rahul K., et al.
Publicado: (2023)

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model
por: de Wit, Emmie, et al.
Publicado: (2022)

Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques
por: Rosenke, Kyle, et al.
Publicado: (2023)

Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus Macaques
por: Rosenke, Kyle, et al.
Publicado: (2022)

A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
por: Hassan, Ahmed O., et al.
Publicado: (2021)

Sex ratios and bimaturism differ between temperature-dependent and genetic sex-determination systems in reptiles
por: Bókony, Veronika, et al.
Publicado: (2019)

Three-Week Old Pigs Are Not Susceptible to Productive Infection with SARS-COV-2
por: Haddock, Elaine, et al.
Publicado: (2022)

Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine
por: O'Donnell, Kyle L., et al.
Publicado: (2023)

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2
por: Rosenke, Kyle, et al.
Publicado: (2020)

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
por: Rosenke, Kyle, et al.
Publicado: (2022)

Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model
por: Rosenke, Kyle, et al.
Publicado: (2022)

A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
por: An, Yaling, et al.
Publicado: (2022)

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models
por: Rosenke, Kyle, et al.
Publicado: (2020)

SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
por: Hansen, Frederick, et al.
Publicado: (2022)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Mastomys natalensis Has a Cellular Immune Response Profile Distinct from Laboratory Mice
por: Tang-Huau, Tsing-Lee, et al.
Publicado: (2021)

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020)

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020)

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
por: Monath, Thomas P., et al.
Publicado: (2023)

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine
por: Furuyama, Wakako, et al.
Publicado: (2021)

SG-APSIC1011: Factors associated with improved knowledge of COVID-19 prevention and control following a training of healthcare workers in Vietnam
por: Nguyen, Hoang, et al.
Publicado: (2023)

SG-APSIC1035: Prospective safety surveillance study of ACAM2000 smallpox vaccine in deployed military personnel
por: Yeo, Kevin, et al.
Publicado: (2023)

SG-APSIC1155: Drug susceptibility patterns of fulminant group G Streptococcus (GGS) infection as a re-emerging infectious disease in Japan
por: Minami, Masaaki, et al.
Publicado: (2023)

SG-APSIC1042: Cutaneous cryptococcosis in patient with advanced HIV disease: Is it possible to give antifungal monotherapy?
por: Irawan, Visakha Revana, et al.
Publicado: (2023)

Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021)

Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine
por: Furuyama, Wakako, et al.
Publicado: (2022)

Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2
por: Munster, Vincent J., et al.
Publicado: (2020)

Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster
por: Clancy, Chad S., et al.
Publicado: (2023)

Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
por: Marzi, Andrea, et al.
Publicado: (2012)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i2o92c5cgmbuouf209c50nod3d